INTRODUCTIONThere are an estimated 3.5 million cases of non-melanoma skin cancer (NMSC), and over 100,000 new cases of malignant melanoma (MM) in the United States each year.1-6 The incidence of…
Read More
INTRODUCTIONThe incidence of non-melanoma skin cancer (NMSC) in the United States is approximately 5 million annual cases per year.1 While surgery is the gold standard for the management of NMSC,…
Read More
INTRODUCTIONNeuromodulator injections have become the leading minimally invasive cosmetic procedure in the United States with an increase of 759% when compared to the year 2000.1 Of the 6,757,198 neuromodulator injections…
Read More
INTRODUCTIONWhile ASAPS statistics show that liposuction continues to be the most popular aesthetic surgical procedure in the US,1 the field of nonsurgical fat reduction is rapidly expanding.2,3 However, devices that…
Read More
INTRODUCTIONPsoriasis is a chronic, inflammatory skin condition characterized by thick plaques with silvery scale.1 These psoriatic plaques commonly occur on the scalp, face, hands, feet, nails, genital regions and skin…
Read More
INTRODUCTIONMinimally invasive soft-tissue augmentation of the face with volumizing fillers has become a popular alternative to traditional surgical procedures such as facelifts.1 One of the more widely used agents is…
Read More
INTRODUCTIONBiotin, also known as Vitamin B7 or vitamin H (the H comes from Haar und Haut, German for “hair and skin”), is a water-soluble B vitamin that acts as an…
Read More
INTRODUCTIONAs we develop, our normal body functions begin to slow down. There is a reduction in the number of fibroblasts, along with a significant loss in their biosynthetic capacity.¹ Consequently,…
Read More
INTRODUCTIONRuxolitinib selectively inhibits JAK1 and JAK2, two molecules of the Janus kinase (JAK) family.1 JAKs are tyrosine kinases connected in pairs to intracellular domains of transmembrane receptors. Many patients with…
Read More
INTRODUCTIONTumor cells evade cytotoxic T-cell activity by expressing PD-1 ligands on their cell surface. Anti-PD-1 and PD-L1 therapeutic antibodies induce long-lasting anti-tumor responses in patients with advanced solid tumors, including…
Read More
INTRODUCTIONThe immune system is the primary factor restraining melanocyte proliferation. Therefore, it should not be surprising that melanoma is more common in the immunosuppressed population, including patients receiving chemotherapy and…
Read More
The incidence of actinic keratoses (AKs), a common dermatologic diagnosis, is likely to continue to grow in the United States in coming years. AKs develop as a response to cumulative…
Read More
